Tropical Journal of Pharmaceutical Research
Pharmacotherapy Group, Faculty of Pharmacy, University of Benin, Benin City, Nigeria
Vol. 15, No. 3, 2016, pp. 631-638
Bioline Code: pr16084
Full paper language: English
Document type: Research Article
Document available free of charge
Tropical Journal of Pharmaceutical Research, Vol. 15, No. 3, 2016, pp. 631-638
© Copyright 2016 - Tropical Journal of Pharmaceutical Research
Pharmacokinetic Interaction between Magnolol and Piperine in Rats|
Chen, Xiao-Ying; Yang, Guang-Hua; Li, Cai-Lan; Yu, Xiu-Ting; Wang, Xiu-Fen; Zheng, Yi-Feng; Xie, Jian-Hui; Lai, Xiao-Ping; Su, Zi-Ren; Liang, Yong-Zhuo & Lin, Ji
Purpose: To investigate the pharmacokinetic mechanism of interaction between magnolol and piperine
when co-administered to rats.
Methods: The rats were divided into five groups as follows: magnolol group (625 mg/kg); low dose of
piperine group (20 mg/kg); high dose of piperine group (40 mg/kg); low dose of piperine + magnolol
group; or high dose of piperine + magnolol group. Plasma samples were collected at regular time
intervals after administration of a single dose of magnolol (625 mg/kg, p.o.) alone or piperine (20 or 40
mg/kg, p.o.) in the presence or absence of magnolol (625 mg/kg, p.o.). The concentrations of magnolol
and piperine in plasma were measured by a validated high performance liquid chromatography (HPLC)
Results: Compared with control, the groups given magnolol alone, concomitant administration of
piperine and magnolol resulted in significant decrease (p < 0.01) in the AUC and Cmax of magnolol.
Interestingly, compared with administration of piperine alone (20 mg/kg), co-administration with
magnolol did not significantly (p > 0.05) alter the pharmacokinetic parameters of piperine. However, at
high dose (40 mg/kg) of piperine, Cmax of piperine significantly decreased from 4.30 ± 1.47 to 2.50 ±
0.78 μg/mL (p < 0.05).
Conclusion: Co-administration of magnolol and piperine decreases plasma concentration of either drug
in rats, suggesting that concurrent use of magnolol with piperine or piperine-containing diets would
require close monitoring for potential interactions.
Magnolol; Piperine; Pharmacokinetic interaction; Co-administration
Alternative site location: http://www.tjpr.org